In the carcinoma subset, 4 of five patients demonstrated an aberration leading to activation of the PI3K/AKT/mTOR pathway, suggesting that activation of this cascade was more closely associated with this histologic subset when compared to the other 4 subsets. Here, PIK3CA is linked to carcinoma.